Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01888887 · ClinicalTrials.gov registry record · NA
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01888887: Completed NA study, sponsored by Galderma R&D.
NCT01888887 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01888887, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin
Primary Outcome
9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks will be conducted to test the reaction of the skin to the test product
Interventions
- OTHER Cetaphil Daily Facial Cleanser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-12 |
| Phase | NA |
What the finished NCT01888887 record still lists
NCT01888887 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Daily Facial Cleanser is the first listed.
NCT01888887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01888887 about?
NCT01888887 is a clinical study titled "Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser". Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin
What is the current status of trial NCT01888887?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-12.
What interventions are being tested in trial NCT01888887?
The interventions under investigation include: Cetaphil Daily Facial Cleanser (OTHER).
Who is sponsoring clinical trial NCT01888887?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01888887's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia